{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:40:18Z","timestamp":1760064018598,"version":"build-2065373602"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ccc.2022.07.007","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:05:34Z","timestamp":1664582734000},"page":"171-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuropharmacology in the Intensive Care Unit"],"prefix":"10.1016","volume":"39","author":[{"given":"Abdalla","family":"Ammar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eljim P.","family":"Tesoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccc.2022.07.007_bib1","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-199902000-00034","article-title":"A\u00a0review of the use of fentanyl analgesia in the management of acute pain in adults","volume":"90","author":"Peng","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccc.2022.07.007_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/L17-0612","article-title":"Opioids and chest wall rigidity during mechanical ventilation","volume":"168","author":"Roan","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1378\/chest.12-2131","article-title":"Fentanyl-induced chest wall rigidity","volume":"143","author":"Coruh","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ccc.2022.07.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ccc.2022.07.007_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/j.1552-4604.1981.tb05693.x","article-title":"Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects","volume":"21","author":"Vallner","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ccc.2022.07.007_bib7","first-page":"84","article-title":"Hydromorphone: pharmacology and clinical applications in cancer patients","volume":"9","author":"Sarhill","year":"2001","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ccc.2022.07.007_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1526-4637.2002.02047.x","article-title":"Methadone reincarnated: novel clinical applications with related concerns","volume":"3","author":"Fishman","year":"2002","journal-title":"Pain Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/109662104773709431","article-title":"Methadone for pain: No. 75","volume":"7","author":"Gazelle","year":"2004","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib10","doi-asserted-by":"crossref","first-page":"1113-e88","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ccc.2022.07.007_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","article-title":"The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit","volume":"101","author":"Pandey","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ccc.2022.07.007_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(08)60105-1","article-title":"Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial","volume":"371","author":"Girard","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2022.07.007_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(09)62072-9","article-title":"A\u00a0protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial","volume":"375","author":"Strom","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2022.07.007_bib14","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/CCM.0b013e3182a16898","article-title":"Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials","volume":"41","author":"Fraser","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00134-014-3214-y","article-title":"Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel","volume":"40","author":"Sharshar","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-016-1294-5","article-title":"Optimizing sedation in patients with acute brain injury","volume":"20","author":"Oddo","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ccc.2022.07.007_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"year":"2020","series-title":"DIPRIVAN (propofol injection epiLZ","key":"10.1016\/j.ccc.2022.07.007_bib19"},{"key":"10.1016\/j.ccc.2022.07.007_bib20","article-title":"Dexmedetomidine in current anaesthesia practice- a review","volume":"8","author":"Naaz","year":"2014","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.ccc.2022.07.007_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0885066615620592","article-title":"Ketamine for analgosedation in the intensive care unit: a systematic review","volume":"32","author":"Patanwala","year":"2017","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00003246-198309000-00012","article-title":"Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients","volume":"11","author":"Lippmann","year":"1983","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcrc.2016.05.016","article-title":"Ketamine for analgosedation in critically ill patients","volume":"35","author":"Erstad","year":"2016","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0310057X9702500308","article-title":"Adverse cardiovascular effects of ketamine infusion in patients with catecholamine-dependent heart failure","volume":"25","author":"Christ","year":"1997","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00007611-199503000-00008","article-title":"Pentobarbital sedation for patients in the pediatric intensive care unit","volume":"88","author":"Tobias","year":"1995","journal-title":"South Med J"},{"key":"10.1016\/j.ccc.2022.07.007_bib26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/phar.2017","article-title":"Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations","volume":"37","author":"Gagnon","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ccc.2022.07.007_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ANA.0b013e3182978ff0","article-title":"Clonidine induces sedation through acting on the perifornical area and the locus coeruleus in rats","volume":"25","author":"Sakamoto","year":"2013","journal-title":"J\u00a0Neurosurg Anesthesiol"},{"year":"2019","series-title":"USP [prescribing information]","author":"Midazolam injection","key":"10.1016\/j.ccc.2022.07.007_bib28"},{"year":"2008","series-title":"USP [prescribing information]","author":"Lorazepam injection","key":"10.1016\/j.ccc.2022.07.007_bib29"},{"key":"10.1016\/j.ccc.2022.07.007_bib30","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1471-4159.1986.tb08491.x","article-title":"Cerebrovascular permeability coefficients to sodium, potassium, and chloride","volume":"46","author":"Smith","year":"1986","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ccc.2022.07.007_bib31","first-page":"231","article-title":"Cerebral hemodynamics in patients with acute severe head trauma","volume":"64","author":"Messeter","year":"1986","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ccc.2022.07.007_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1227\/00006123-198708000-00003","article-title":"Cerebral perfusion pressure: a hemodynamic mechanism of mannitol and the postmannitol hemogram","volume":"21","author":"Rosner","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ccc.2022.07.007_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.CCM.0000120057.04528.60","article-title":"Osmole gap in neurologic-neurosurgical intensive care unit: its normal value, calculation, and relationship with mannitol serum concentrations","volume":"32","author":"Garcia-Morales","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.CON.0000415432.84147.1e","article-title":"Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline","volume":"18","author":"Fink","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.ccc.2022.07.007_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12028-017-0456-x","article-title":"Pharmacotherapy pearls for emergency neurological life support","volume":"27","author":"Brophy","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ncl.2008.02.003","article-title":"Management of intracranial hypertension","volume":"26","author":"Rangel-Castilla","year":"2008","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ccc.2022.07.007_bib37","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2044.2009.05986.x","article-title":"Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure","volume":"64","author":"Strandvik","year":"2009","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ccc.2022.07.007_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0885066617702590","article-title":"Incidence of adverse events during peripheral administration of sodium chloride 3","volume":"33","author":"Dillon","year":"2018","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12028-021-01248-7","article-title":"Safety and efficacy of 23.4% sodium chloride administered via peripheral venous access for the treatment of cerebral herniation and intracranial pressure elevation","volume":"35","author":"Faiver","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2146\/ajhp161028","article-title":"Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults","volume":"75","author":"Meng","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ccc.2022.07.007_bib41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4037\/NCI.0b013e318214564b","article-title":"Management of intracranial hypertension: focus on pharmacologic strategies","volume":"22","author":"Ennis","year":"2011","journal-title":"AACN Adv Crit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the acute treatment of cerebral edema in neurocritical care patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib43","series-title":"Encyclopedia of neuroscience","first-page":"407","article-title":"Brain trauma","author":"Dunn","year":"2009"},{"key":"10.1016\/j.ccc.2022.07.007_bib44","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000221786.81354.d6","article-title":"Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates","volume":"37","author":"Huttner","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ccc.2022.07.007_bib45","doi-asserted-by":"crossref","first-page":"879.e19-25","DOI":"10.1016\/j.amjmed.2016.01.041","article-title":"Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study","volume":"129","author":"Alotaibi","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb","year":"2013","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.ccc.2022.07.007_bib47","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/jth.13697","article-title":"Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis","volume":"15","author":"Melkonian","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ccc.2022.07.007_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2007-998998","article-title":"Molecular interactions of thrombin","volume":"22","author":"Tulinsky","year":"1996","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ccc.2022.07.007_bib49","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.jacc.2017.09.1099","article-title":"Use of fondaparinux off-label or approved anticoagulants for management of heparin-induced thrombocytopenia","volume":"70","author":"Schindewolf","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2022.07.007_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mcp.2002.124522","article-title":"Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender","volume":"71","author":"Robson","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccc.2022.07.007_bib51","doi-asserted-by":"crossref","first-page":"105S-11S","DOI":"10.1592\/phco.22.10.105S.33616","article-title":"Clinical pharmacology of bivalirudin","volume":"22","author":"Reed","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ccc.2022.07.007_bib52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","article-title":"American Heart A, American College of Cardiology f. American Heart Association\/American College of Cardiology Foundation guide to warfarin therapy","volume":"107","author":"Hirsh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2022.07.007_bib53","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ccc.2022.07.007_bib54","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.ccc.2022.07.007_bib55","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.114.014113","article-title":"Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis","volume":"131","author":"Chan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2022.07.007_bib56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/dmd.107.019083","article-title":"The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans","volume":"36","author":"Blech","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"Suppl F","key":"10.1016\/j.ccc.2022.07.007_bib57","first-page":"27F","article-title":"The mechanism of action of thrombin inhibitors","volume":"12","author":"Bates","year":"2000","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.ccc.2022.07.007_bib58","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.2174\/138161208784246135","article-title":"Pharmacological strategies for inhibition of thrombin activity","volume":"14","author":"Alban","year":"2008","journal-title":"Curr Pharm Des"},{"year":"2010","series-title":"COUMADIN(R) oral tablets ii, warfarin sodium oral tablets, intravenous injection","key":"10.1016\/j.ccc.2022.07.007_bib59"},{"key":"10.1016\/j.ccc.2022.07.007_bib60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/STROKEAHA.118.023840","article-title":"Contemporary reversal of oral anticoagulation in intracerebral hemorrhage","volume":"50","author":"Bower","year":"2019","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1016\/j.ccc.2022.07.007_bib62","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/s12028-015-0158-1","article-title":"Emergency neurological life support: pharmacotherapy","volume":"23","author":"Brophy","year":"2015","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib63","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.hrthm.2019.01.024","volume":"16","author":"Writing Group","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccc.2022.07.007_bib64","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/0897190010372321","article-title":"Pharmacological management of seizures and status epilepticus in critically ill patients","volume":"23","author":"Tesoro","year":"2010","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.ccc.2022.07.007_bib65","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12028-017-0460-1","article-title":"Emergency neurological life support: status epilepticus","volume":"27","author":"Claassen","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib67","first-page":"1","article-title":"A\u00a0review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Klein","year":"2018","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.ccc.2022.07.007_bib68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ncl.2021.01.009","article-title":"Evaluation and management of seizures and status epilepticus","volume":"39","author":"Ameli","year":"2021","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ccc.2022.07.007_bib69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.0000079019.02601.90","article-title":"Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation","volume":"108","author":"Nolan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2022.07.007_bib70","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3109\/02699052.2012.661120","article-title":"Therapeutic hypothermia for the management of intracranial hypertension in severe traumatic brain injury: a systematic review","volume":"26","author":"Sadaka","year":"2012","journal-title":"Brain Inj"},{"key":"10.1016\/j.ccc.2022.07.007_bib71","first-page":"CD001048","article-title":"Hypothermia for traumatic brain injury","volume":"9","author":"Lewis","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccc.2022.07.007_bib72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12028-010-9474-7","article-title":"Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol","volume":"14","author":"Choi","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12028-009-9280-2","article-title":"Effect of shivering on brain tissue oxygenation during induced normothermia in patients with severe brain injury","volume":"12","author":"Oddo","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ccc.2022.07.007_bib74","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1161\/STROKEAHA.108.523654","article-title":"Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale","volume":"39","author":"Badjatia","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ccc.2022.07.007_bib75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/JNN.0000000000000340","article-title":"Shivering treatments for targeted temperature management: a review","volume":"50","author":"Jain","year":"2018","journal-title":"J\u00a0Neurosci Nurs"},{"key":"10.1016\/j.ccc.2022.07.007_bib76","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1476-5381.2011.01588.x","article-title":"Use of inotropes and vasopressor agents in critically ill patients","volume":"165","author":"Bangash","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ccc.2022.07.007_bib77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1164\/rccm.201006-0972CI","article-title":"Vasoactive drugs in circulatory shock","volume":"183","author":"Hollenberg","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccc.2022.07.007_bib78","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2146\/ajhp080348.p2","article-title":"Intravenous therapy for hypertensive emergencies, part 2","volume":"66","author":"Rhoney","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ccc.2022.07.007_bib79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccl.2005.09.002","article-title":"Hypertensive crisis: hypertensive emergencies and urgencies","volume":"24","author":"Aggarwal","year":"2006","journal-title":"Cardiol Clin"},{"issue":"6","key":"10.1016\/j.ccc.2022.07.007_bib80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1756285609344375","article-title":"Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms","volume":"2","author":"Awad","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"issue":"7","key":"10.1016\/j.ccc.2022.07.007_bib81","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ccc.2022.07.007_bib82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neurol.2017.11.005","article-title":"Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders","volume":"174","author":"Ciron","year":"2018","journal-title":"Rev Neurol (Paris)"},{"issue":"20","key":"10.1016\/j.ccc.2022.07.007_bib83","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1212\/WNL.0000000000003331","article-title":"Rituximab in multiple sclerosis: a retrospective observational study on safety and efficacy","volume":"87","author":"Salzer","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ccc.2022.07.007_bib84","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/mus.21521","article-title":"Rituximab in the management of refractory myasthenia gravis","volume":"41","author":"Zebardast","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ccc.2022.07.007_bib85","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamaneurol.2020.5407","article-title":"Comparison of corticosteroid tapering regimens in myasthenia gravis: a randomized clinical trial","volume":"78","author":"Sharshar","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ccc.2022.07.007_bib86","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fneur.2020.00604","article-title":"A\u00a0practical approach to managing patients with myasthenia gravis-opinions and a review of the literature","volume":"11","author":"Farrugia","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.ccc.2022.07.007_bib87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ana.410370108","article-title":"Low-dose (7.5\u00a0mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis","volume":"37","author":"Goodkin","year":"1995","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.ccc.2022.07.007_bib88","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"issue":"10031","key":"10.1016\/j.ccc.2022.07.007_bib89","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","article-title":"Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Villiger","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccc.2022.07.007_bib90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s13311-019-00776-7","article-title":"Extending the interval of natalizumab dosing: is efficacy preserved?","volume":"17","author":"Clerico","year":"2020","journal-title":"Neurotherapeutics"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070422000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070422000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:23:22Z","timestamp":1760063002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070422000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0749070422000574"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2022.07.007","relation":{},"ISSN":["0749-0704"],"issn-type":[{"type":"print","value":"0749-0704"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropharmacology in the Intensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2022.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}